Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it ...
With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...
Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...
To accelerate growth, Zimmer Biomet has focused on penetrating ambulatory surgical centers as procedures migrate to ... of its Oxford partial cementless knee. While Oxford has been a dominant ...
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the ...
Fifth Third Bancorp lessened its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 2.5% in the fourth ...
(Reuters) - Medical device maker Zimmer Biomet Holdings forecast full-year ... due to strong demand for its devices used in hip and knee procedures. Combined sales at Zimmer's hips and knees ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results